| Literature DB >> 31485369 |
Yanni Tai1,2, Fuxian Zou1,2, Qiurong Zhang1, Jia Wang1, Ronghui Rao3, Ruihua Xie1, Shuisheng Wu1, Kedan Chu1,2, Wen Xu1,2, Xiaoyan Li1, Mingqing Huang1,2.
Abstract
Rhizoma Alismatis (RA), widely known as "Ze-Xie" in China, is the tuber of Alisma orientale (Sam.) Juzep (Alismaceae), a Chinese herbal medicine that has been used to treat hyperlipidemia, diabetes, hypertension, dysuria, and inflammation. In this study, a sensitive and reliable method based on an ultra-performance liquid chromatography (UPLC) couple with two ionisation modes, including electrospray ionisation (ESI) and atmospheric pressure chemical ionisation (APCI) tandem mass spectrometry (MS), namely, UPLC-ESI/APCI-MS/MS was developed and validated to simultaneously determine 8 triterpenoids (ESI mode) and 2 sesquiterpenoids (APCI mode) in RA. Ten marker compounds were analysed with a Waters' CORTECS UPLC C18 column (200 mm × 2.1 m, 1.6 μm) and gradient elution with water (contained 0.1% formic) and acetonitrile within 7 min. The established method was validated for linearity, intra- and interday precisions, accuracy, recovery, and stability. The calibration curve for 10 marker compounds showed good linear regression (r > 0.9971). The limits of detection and quantification for analytes were 0.14-1.67 ng/mL and 0.44-5.65 ng/mL, respectively. The relative standard deviations (RSD, %) and accuracy (RE, %) of intra- and interday precisions were less than 3.83% and 1.21% and 3.22% and 1.46%, repeatability and stability for real samples were less than 2.78% and 3.19%, respectively. All recoveries of the 10 marker compounds ranged from 97.24% to 102.49% with RSDs less than 4.05%. The developed method efficiently determined the 10 marker compounds in RA and was subsequently applied to optimise harvest time and crude processing temperature. The result indicated the 90% wilted phase and 70°C (or lower) may be the best harvest time and the processing temperature of RA.Entities:
Year: 2019 PMID: 31485369 PMCID: PMC6710727 DOI: 10.1155/2019/8320171
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.193
Figure 1Chemical structures of the 10 investigated compounds and 1 internal standard.
Figure 2Different wilt stages of RA. (a) Stage I. (b) Stage II. (c) Stage III. (d) Stage IV. (e) Stage V. (f) Stage VI.
Figure 3Optimisation of multiple reaction monitoring product ions, APCI-MS/MS spectra and the proposed fragmentation pathway of alismoxide (a) and alismol (b).
Retention time, related MS data of the 10 investigated compounds, and internal standards in the UPLC-APCI/ESI-MS/MS analysis.
| Compounds |
| Fragment ions ( | Cone voltage (V) | Collision energy (eV) | Ionisation modes |
|---|---|---|---|---|---|
| Alismoxide | 1.48 | 203.1 ⟶ 161.0; | 15 | 15 | APCI+ |
| Alisol C | 2.05 |
| 35 | 15 | ESI+ |
| Alisol C 23-acetate | 2.57 | 529.3 ⟶ 511.3; 529.3 ⟶ 469.3; | 30 | 20 | ESI+ |
| Alisol A | 3.03 | 473.3 ⟶ 337.0; 473.3 ⟶ 365.3; | 40 | 11 | ESI+ |
| Alisol A 24-acetate | 3.5 |
| 20 | 10 | ESI+ |
| Alismol | 3.64 | 203.1 ⟶ 161.0; | 10 | 12 | APCI+ |
| Alisol B | 4.23 | 455.1 ⟶ 437.0; 455.1 ⟶ 383.1; 455.1 ⟶ 379.1; | 40 | 27 | ESI+ |
| Alisol B 23-acetate | 4.99 | 497.1 ⟶ 479.1; | 40 | 8 | ESI+ |
| 11-Deoxyalisol B | 5.81 |
| 40 | 10 | ESI+ |
| 11-Deoxyalisol B 23-acetate | 6.68 |
| 35 | 12 | ESI+ |
| Glycyrrhetnic acid (IS) | 3.76 | 417.3 ⟶ 317.2 | 35 | 12 | ESI+ |
∗Quantitative ion pair.
Figure 4UPLC-ESI/APCI-MS/MS chromatogram of 10 target standards and 1 internal standard of standard solution (a) and RA sample (b). AX: alismoxide; C: alisol C; 23C: alisol C 23-acetate; A: alisol A; 24A: alisol A 24-acetate; AL: alismol; B: alisol B; 23B: alisol B 23-acetate; 11-B: 11-deoxyalisol B; 11-23B: 11-deoxyalisol B 23-acetate.
Regression equation, LODs, and LOQs of the 10 investigated compounds.
| Compound | Regression equations | Linear range (ng·mL−1) |
| LODs (ng·ml−1) | LOQs (ng·ml−1) |
|---|---|---|---|---|---|
| Alismoxide |
| 1.021–1021 | 0.9999 | 0.16 | 0.51 |
| Alisol C |
| 4.928–492.8 | 0.9998 | 0.82 | 1.64 |
| Alisol C 23-acetate |
| 5.105–5105 | 0.9997 | 0.73 | 2.55 |
| Alisol A |
| 0.872–872.0 | 0.9999 | 0.14 | 0.44 |
| Alisol A 24-acetate |
| 3.12–3120 | 0.9990 | 0.51 | 1.25 |
| Alismol |
| 3.00–3000 | 0.9998 | 0.48 | 1.51 |
| Alisol B |
| 7.728–7728 | 0.9985 | 0.62 | 3.86 |
| Alisol B 23-acetate |
| 11.3–11300 | 0.9971 | 1.67 | 5.65 |
| 11-Deoxyalisol B |
| 3.432–3432 | 0.9985 | 0.46 | 1.72 |
| 11-Deoxyalisol B 23-acetate |
| 5.348–5348 | 0.9997 | 0.93 | 1.18 |
Contents of the 10 investigated compounds in 36 batches of RA harvesting samples. AX: alismoxide, C alisol C 23C: alisol C 23-acetate, A alisol A 24A: alisol A 24-acetate, AL: alismol, B alisol B 23B: alisol B 23-acetate, 11-B: 11-deoxyalisol B 11-23B: 11-deoxyalisol B 23-acetate.
| Sample code | AX | C | 23C | A | 24A | AL | B | 23B | 11-B | 11-23B |
|---|---|---|---|---|---|---|---|---|---|---|
| Stage I–1 | 0.022 | 0.153 | 0.288 | 0.022 | 0.013 | 0.172 | 0.310 | 0.538 | 0.094 | 0.037 |
| Stage I–2 | 0.017 | 0.164 | 0.345 | 0.025 | 0.017 | 0.158 | 0.290 | 0.698 | 0.083 | 0.070 |
| Stage I–3 | 0.017 | 0.195 | 0.329 | 0.018 | 0.012 | 0.129 | 0.257 | 0.845 | 0.093 | 0.056 |
| Stage I–4 | 0.025 | 0.174 | 0.351 | 0.028 | 0.010 | 0.212 | 0.293 | 0.749 | 0.110 | 0.083 |
| Stage I–5 | 0.015 | 0.152 | 0.318 | 0.021 | 0.015 | 0.284 | 0.266 | 0.865 | 0.097 | 0.090 |
| Stage I–6 | 0.021 | 0.173 | 0.323 | 0.017 | 0.015 | 0.200 | 0.284 | 0.752 | 0.126 | 0.046 |
|
| ||||||||||
| Stage II–1 | 0.025 | 0.135 | 0.246 | 0.020 | 0.021 | 0.216 | 0.285 | 0.966 | 0.116 | 0.043 |
| Stage II–2 | 0.018 | 0.122 | 0.335 | 0.020 | 0.020 | 0.218 | 0.246 | 0.831 | 0.100 | 0.057 |
| Stage II–3 | 0.022 | 0.119 | 0.314 | 0.027 | 0.020 | 0.236 | 0.307 | 0.829 | 0.105 | 0.046 |
| Stage II–4 | 0.023 | 0.120 | 0.276 | 0.028 | 0.027 | 0.239 | 0.330 | 0.883 | 0.116 | 0.084 |
| Stage II–5 | 0.028 | 0.143 | 0.303 | 0.022 | 0.024 | 0.205 | 0.291 | 0.762 | 0.123 | 0.115 |
| Stage II–6 | 0.022 | 0.147 | 0.288 | 0.022 | 0.024 | 0.217 | 0.352 | 0.767 | 0.132 | 0.063 |
|
| ||||||||||
| Stage III–1 | 0.030 | 0.139 | 0.238 | 0.029 | 0.026 | 0.226 | 0.326 | 0.747 | 0.104 | 0.066 |
| Stage III–2 | 0.032 | 0.128 | 0.285 | 0.035 | 0.039 | 0.222 | 0.303 | 0.718 | 0.099 | 0.059 |
| Stage III–3 | 0.034 | 0.111 | 0.238 | 0.028 | 0.031 | 0.210 | 0.267 | 0.802 | 0.088 | 0.064 |
| Stage III–4 | 0.033 | 0.123 | 0.216 | 0.030 | 0.030 | 0.219 | 0.301 | 1.049 | 0.104 | 0.077 |
| Stage III–5 | 0.034 | 0.094 | 0.291 | 0.029 | 0.034 | 0.231 | 0.326 | 0.924 | 0.090 | 0.108 |
| Stage III–6 | 0.026 | 0.123 | 0.225 | 0.027 | 0.034 | 0.197 | 0.360 | 0.998 | 0.104 | 0.063 |
|
| ||||||||||
| Stage IV–1 | 0.029 | 0.090 | 0.181 | 0.053 | 0.077 | 0.252 | 0.319 | 1.034 | 0.136 | 0.041 |
| Stage IV–2 | 0.037 | 0.087 | 0.199 | 0.064 | 0.081 | 0.287 | 0.319 | 0.999 | 0.106 | 0.059 |
| Stage IV–3 | 0.031 | 0.088 | 0.160 | 0.055 | 0.070 | 0.271 | 0.363 | 0.993 | 0.137 | 0.094 |
| Stage IV–4 | 0.033 | 0.084 | 0.182 | 0.058 | 0.075 | 0.266 | 0.494 | 1.253 | 0.175 | 0.091 |
| Stage IV–5 | 0.038 | 0.097 | 0.157 | 0.054 | 0.062 | 0.313 | 0.344 | 1.201 | 0.154 | 0.113 |
| Stage IV–6 | 0.036 | 0.092 | 0.170 | 0.062 | 0.068 | 0.260 | 0.368 | 1.078 | 0.134 | 0.069 |
|
| ||||||||||
| Stage V–1 | 0.029 | 0.071 | 0.150 | 0.033 | 0.034 | 0.376 | 0.634 | 1.488 | 0.216 | 0.057 |
| Stage V–2 | 0.030 | 0.081 | 0.173 | 0.031 | 0.038 | 0.412 | 0.610 | 1.477 | 0.195 | 0.062 |
| Stage V–3 | 0.028 | 0.073 | 0.159 | 0.039 | 0.037 | 0.423 | 0.674 | 1.399 | 0.230 | 0.066 |
| Stage V–4 | 0.032 | 0.084 | 0.156 | 0.028 | 0.041 | 0.379 | 0.639 | 1.460 | 0.252 | 0.108 |
| Stage V–5 | 0.028 | 0.083 | 0.146 | 0.032 | 0.031 | 0.402 | 0.565 | 1.544 | 0.234 | 0.121 |
| Stage V–6 | 0.032 | 0.080 | 0.159 | 0.036 | 0.033 | 0.433 | 0.607 | 1.538 | 0.211 | 0.073 |
|
| ||||||||||
| Stage VI–1 | 0.029 | 0.131 | 0.204 | 0.036 | 0.028 | 0.315 | 0.439 | 0.742 | 0.165 | 0.047 |
| Stage VI–2 | 0.036 | 0.124 | 0.222 | 0.043 | 0.032 | 0.434 | 0.363 | 0.819 | 0.193 | 0.067 |
| Stage VI–3 | 0.035 | 0.102 | 0.235 | 0.031 | 0.024 | 0.457 | 0.343 | 0.828 | 0.186 | 0.081 |
| Stage VI–4 | 0.027 | 0.134 | 0.193 | 0.035 | 0.034 | 0.428 | 0.357 | 0.701 | 0.169 | 0.098 |
| Stage VI–5 | 0.032 | 0.105 | 0.177 | 0.031 | 0.031 | 0.517 | 0.362 | 0.882 | 0.196 | 0.103 |
| Stage VI–6 | 0.030 | 0.100 | 0.204 | 0.035 | 0.030 | 0.445 | 0.436 | 0.949 | 0.208 | 0.066 |
Figure 5Broken line diagram of the contents of 10 compounds in RA harvesting samples (a). Variation histogram of the total compounds in RA harvesting samples in 6 stages (b). Variation histogram of total triterpenoids and two sesquiterpenoids in the harvesting samples in 6 stages (c). AX: alismoxide, C: alisol C 23C: alisol C 23-acetate, A alisol A 24A: alisol A 24-acetate, AL: alismol, B alisol B 23B: alisol B 23-acetate, 11-B: 11-deoxyalisol B 11-23B: 11-deoxyalisol B 23-acetate.
Contents of the 10 investigated compounds in 42 batches of different RA dry temperature samples. AX: alismoxide, C alisol C 23C: alisol C 23-acetate, A alisol A 24A: alisol A 24-acetate, AL: alismol, B alisol B 23B: alisol B 23-acetate, 11-B: 11-deoxyalisol B 11-23B: 11-deoxyalisol B 23-acetate.
| Sample no. | AX | C | 23C | A | 24A | AL | B | 23B | 11-B | 11-23B |
|---|---|---|---|---|---|---|---|---|---|---|
| Freeze-dried–1 | 0.030 | 0.074 | 0.146 | 0.033 | 0.034 | 0.393 | 0.641 | 1.489 | 0.230 | 0.097 |
| Freeze-dried–2 | 0.030 | 0.078 | 0.179 | 0.031 | 0.039 | 0.440 | 0.626 | 1.473 | 0.201 | 0.120 |
| Freeze-dried–3 | 0.029 | 0.085 | 0.166 | 0.039 | 0.040 | 0.391 | 0.673 | 1.420 | 0.232 | 0.114 |
| Freeze-dried–4 | 0.032 | 0.072 | 0.163 | 0.032 | 0.044 | 0.382 | 0.632 | 1.472 | 0.242 | 0.115 |
| Freeze-dried–5 | 0.028 | 0.084 | 0.150 | 0.033 | 0.035 | 0.430 | 0.567 | 1.580 | 0.242 | 0.125 |
| Freeze-dried–6 | 0.032 | 0.080 | 0.161 | 0.037 | 0.034 | 0.439 | 0.619 | 1.549 | 0.220 | 0.109 |
|
| ||||||||||
| 60°C–1 | 0.026 | 0.069 | 0.163 | 0.042 | 0.045 | 0.362 | 0.588 | 1.413 | 0.211 | 0.093 |
| 60°C–2 | 0.028 | 0.071 | 0.169 | 0.039 | 0.046 | 0.417 | 0.596 | 1.323 | 0.200 | 0.103 |
| 60°C–3 | 0.025 | 0.059 | 0.163 | 0.037 | 0.046 | 0.403 | 0.620 | 1.477 | 0.205 | 0.096 |
| 60°C–4 | 0.026 | 0.057 | 0.150 | 0.031 | 0.044 | 0.356 | 0.577 | 1.339 | 0.216 | 0.101 |
| 60°C–5 | 0.028 | 0.063 | 0.156 | 0.047 | 0.050 | 0.396 | 0.548 | 1.412 | 0.195 | 0.110 |
| 60°C–6 | 0.024 | 0.060 | 0.163 | 0.049 | 0.041 | 0.393 | 0.571 | 1.381 | 0.177 | 0.099 |
|
| ||||||||||
| 70°C–1 | 0.025 | 0.055 | 0.143 | 0.045 | 0.055 | 0.341 | 0.516 | 1.179 | 0.198 | 0.089 |
| 70°C–2 | 0.027 | 0.050 | 0.154 | 0.046 | 0.050 | 0.367 | 0.564 | 1.374 | 0.206 | 0.086 |
| 70°C–3 | 0.024 | 0.055 | 0.156 | 0.046 | 0.042 | 0.377 | 0.544 | 1.248 | 0.186 | 0.081 |
| 70°C–4 | 0.025 | 0.055 | 0.148 | 0.044 | 0.049 | 0.347 | 0.570 | 1.160 | 0.197 | 0.089 |
| 70°C–5 | 0.024 | 0.049 | 0.143 | 0.050 | 0.055 | 0.372 | 0.548 | 1.265 | 0.174 | 0.094 |
| 70°C–6 | 0.024 | 0.050 | 0.154 | 0.051 | 0.044 | 0.361 | 0.528 | 1.184 | 0.190 | 0.079 |
|
| ||||||||||
| 80°C–1 | 0.020 | 0.037 | 0.113 | 0.085 | 0.113 | 0.303 | 0.411 | 0.881 | 0.150 | 0.064 |
| 80°C–2 | 0.019 | 0.046 | 0.128 | 0.080 | 0.143 | 0.268 | 0.456 | 0.933 | 0.139 | 0.068 |
| 80°C–3 | 0.018 | 0.044 | 0.117 | 0.082 | 0.140 | 0.304 | 0.430 | 1.017 | 0.127 | 0.073 |
| 80°C–4 | 0.016 | 0.046 | 0.120 | 0.099 | 0.116 | 0.309 | 0.491 | 0.856 | 0.131 | 0.062 |
| 80°C–5 | 0.019 | 0.039 | 0.104 | 0.075 | 0.129 | 0.296 | 0.435 | 0.823 | 0.141 | 0.060 |
| 80°C–6 | 0.021 | 0.043 | 0.121 | 0.074 | 0.120 | 0.272 | 0.474 | 0.806 | 0.140 | 0.057 |
|
| ||||||||||
| 100°C–1 | 0.019 | 0.039 | 0.088 | 0.131 | 0.165 | 0.245 | 0.376 | 0.706 | 0.119 | 0.063 |
| 100°C–2 | 0.018 | 0.035 | 0.083 | 0.119 | 0.185 | 0.272 | 0.305 | 0.782 | 0.107 | 0.071 |
| 100°C–3 | 0.017 | 0.038 | 0.092 | 0.121 | 0.190 | 0.241 | 0.377 | 0.830 | 0.103 | 0.067 |
| 100°C–4 | 0.015 | 0.040 | 0.085 | 0.138 | 0.166 | 0.251 | 0.362 | 0.720 | 0.115 | 0.059 |
| 100°C–5 | 0.018 | 0.035 | 0.069 | 0.101 | 0.179 | 0.233 | 0.402 | 0.763 | 0.092 | 0.052 |
| 100°C–6 | 0.020 | 0.039 | 0.092 | 0.121 | 0.157 | 0.221 | 0.349 | 0.836 | 0.101 | 0.055 |
|
| ||||||||||
| 120°C–1 | 0.019 | 0.032 | 0.062 | 0.116 | 0.317 | 0.193 | 0.286 | 0.566 | 0.092 | 0.060 |
| 120°C–2 | 0.018 | 0.027 | 0.078 | 0.159 | 0.296 | 0.234 | 0.314 | 0.616 | 0.088 | 0.056 |
| 120°C–3 | 0.020 | 0.035 | 0.071 | 0.151 | 0.302 | 0.196 | 0.275 | 0.570 | 0.079 | 0.047 |
| 120°C–4 | 0.021 | 0.025 | 0.083 | 0.139 | 0.360 | 0.213 | 0.292 | 0.648 | 0.095 | 0.063 |
| 120°C–5 | 0.014 | 0.029 | 0.088 | 0.128 | 0.292 | 0.189 | 0.339 | 0.695 | 0.081 | 0.049 |
| 120°C–6 | 0.019 | 0.037 | 0.062 | 0.136 | 0.353 | 0.199 | 0.282 | 0.622 | 0.082 | 0.050 |
|
| ||||||||||
| 150°C–1 | 0.012 | 0.028 | 0.051 | 0.169 | 0.471 | 0.137 | 0.227 | 0.522 | 0.054 | 0.048 |
| 150°C–2 | 0.010 | 0.017 | 0.070 | 0.190 | 0.423 | 0.172 | 0.241 | 0.477 | 0.067 | 0.054 |
| 150°C–3 | 0.013 | 0.012 | 0.053 | 0.153 | 0.473 | 0.165 | 0.171 | 0.505 | 0.058 | 0.045 |
| 150°C–4 | 0.010 | 0.028 | 0.050 | 0.161 | 0.521 | 0.148 | 0.225 | 0.427 | 0.051 | 0.048 |
| 150°C–5 | 0.008 | 0.022 | 0.064 | 0.149 | 0.401 | 0.168 | 0.206 | 0.375 | 0.065 | 0.052 |
| 150°C–6 | 0.011 | 0.029 | 0.060 | 0.141 | 0.460 | 0.157 | 0.221 | 0.523 | 0.049 | 0.048 |
Figure 6Different processing temperature of RA.
Figure 7Broken line diagram of the contents of 10 compounds in different RA dry temperature samples (a). Variation histogram of the total compounds in different RA dry temperature samples (b). AX: alismoxide, C: alisol C 23C: alisol C 23-acetate, A alisol A 24A: alisol A 24-acetate, AL: alismol, B alisol B 23B: alisol B 23-acetate, 11-B: 11-deoxyalisol B 11-23B: 11-deoxyalisol B 23-acetate.